Diginex Acquires The Remedy Project to Enhance Human Rights Compliance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 18 2025
0mins
Source: Newsfilter
- Strategic Acquisition: Diginex has successfully signed a definitive share purchase agreement to acquire The Remedy Project, which specializes in human rights in global supply chains, marking a significant milestone in its ESG compliance and supply chain due diligence strategy.
- Growing Market Demand: The increasing stringency of regulations, such as the EU corporate sustainability due diligence directive, has led to a significant rise in demand for effective remediation work, and this acquisition will enhance Diginex's capabilities in technology and advisory services in this area.
- Technology Integration: The acquisition will enhance Diginex's diginexAPPRISE platform by integrating The Remedy Project's expertise in human rights due diligence and remediation mechanisms, thereby improving data transparency and risk identification capabilities.
- Leadership Team Expansion: Archana Kotecha, founder of The Remedy Project, will join Diginex's executive team to focus on remedy innovation and global relationships with corporations and governments, further solidifying the company's leadership position in human rights compliance.
Analyst Views on DGNX
About DGNX
Diginex Ltd is an investment holding company mainly engaged in the software as a service (SaaS) business. The Company operates its businesses through a subsidiary, Diginex Solutions (HK) Limited. Diginex Solutions (HK) Limited is mainly engaged in building end-to-end SaaS solutions for the future of ESG reporting and supply chain due diligence. The Company also provides advisory services to support ESG strategies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
